Circulating N-Linked Glycoprotein Acetyls and Longitudinal Mortality Risk.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Circulation Research

• Publication date

  2016-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/CIRCRESAHA.115.308078PMID 26951635PMCID PMC4836171
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Serum Nuclear Magnetic Resonance Spectroscopy: One More Step toward Clinical Utility.

  2015cited by this paper
• Cotranslational and posttranslocational N-glycosylation of proteins in the endoplasmic reticulum.

  2015cited by this paper
• GlycA: A Composite Nuclear Magnetic Resonance Biomarker of Systemic Inflammation.

  2015cited by this paper
• Novel Protein Glycan Side-Chain Biomarker and Risk of Incident Type 2 Diabetes Mellitus

  2015cited by this paper
• Innate and adaptive inflammation as a therapeutic target in vascular disease: the emerging role of statins.

  2014cited by this paper
• A Review of the Application of Inflammatory Biomarkers in Epidemiologic Cancer Research

  2014cited by this paper
• Glycosyltransferases, glycosylation and atherosclerosis

  2014cited by this paper
• The intrinsic and extrinsic effects of N-linked glycans on glycoproteostasis.

  2014cited by this paper
• Biomarker Profiling by Nuclear Magnetic Resonance Spectroscopy for the Prediction of All-Cause Mortality: An Observational Study of 17,345 Persons

  2014cited by this paper
• A Novel Protein Glycan Biomarker and Future Cardiovascular Disease Events

  2014cited by this paper
• The Role of Chronic Inflammation in Obesity-Associated Cancers

  2013cited by this paper
• Alternate-Day, Low-Dose Aspirin and Cancer Risk: Long-Term Observational Follow-up of a Randomized Trial

  2013cited by this paper
• Relationship of lipoprotein-associated phospholipase A₂ mass and activity with incident vascular events among primary prevention patients allocated to placebo or to statin therapy: an analysis from the JUPITER trial.

  2012cited by this paper
• O-GlcNAc Signaling in the Cardiovascular System

  2010cited by this paper
• C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis

  2010cited by this paper
• Glycomics hits the big time.

  2010cited by this paper
• A glycomics approach to the discovery of potential cancer biomarkers.

  2010cited by this paper
• Glycosylation of Serum Proteins in Inflammatory Diseases

  2009cited by this paper
• Comparison of LDL cholesterol concentrations by Friedewald calculation and direct measurement in relation to cardiovascular events in 27,331 women.

  2009cited by this paper
• Glycosylation in immune cell trafficking

  2009cited by this paper
• Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.

  2008cited by this paper
• Evaluation of the serum N‐linked glycome for the diagnosis of cancer and chronic inflammation

  2008cited by this paper
• Glycosylation in cellular mechanisms of health and disease.

  2006cited by this paper
• Value of an Endpoints Committee versus the use of nosologists for validating cause of death.

  2006cited by this paper
• A Randomized Trial of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease in Women

  2006cited by this paper
• Association of physical activity and body mass index with novel and traditional cardiovascular biomarkers in women.

  2006cited by this paper
• Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer The Women ’ s Health Study : A Randomized Controlled Trial

  2005cited by this paper
• Effects of estrogen with and without progestin on urinary incontinence

  2005cited by this paper
• Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial.

  2005cited by this paper
• Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events*

  2002cited by this paper
• Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events.

  2002cited by this paper
• Assignment of resonances for ‘acute‐phase’ glycoproteins in high resolution proton NMR spectra of human blood plasma

  1987cited by this paper

• A cohort study reveals shared and distinct serum metabolic biomarkers for major adverse cardiovascular events in middle-aged and older adults

  2025cites this paper
• Metabolic Vulnerability Index and Atherosclerosis Incident: A Prospective Cohort Study From the UK Biobank

  2025cites this paper
• Development of Age‐ and Sex‐Specific Metabolomics‐Based Biological Ageing Clocks for 10‐Year Mortality Prediction

  2025cites this paper
• Fibrinogen glycosylation and glycation: molecular insights into thrombosis and vascular disease

  2025cites this paper
• Cross‐sectional and longitudinal metabolomics‐based profiles associated with oral contraceptive and progestin‐only pill use: A Finnish population‐based study

  2025cites this paper
• Exploring Metabolic Signatures: Unraveling the Association with Obesity in Children and Adolescents

  2025cites this paper
• The Role of High-Sensitivity C-Reactive Protein in Activities of Daily Living Among Middle-Aged and Older Adults: A Prospective Cohort Study

  2025cites this paper
• Liver Transplantation and Metabolic Dysfunction Associated Steatotic Liver Disease Is Associated with Markers of Metabolic Risk and Inflammation

  2025cites this paper
• Obesity and sarcopenia affect the metabolite profiles of pet dogs

  2025cites this paper
• Inflammatory markers and frailty in home-dwelling elderly, a cross-sectional study

  2024cites this paper
• The plasma metabolome of juvenile idiopathic arthritis varies according to subtype and underlying inflammatory status

  2024cites this paper
• Metabolomics-Based Machine Learning for Predicting Mortality: Unveiling Multisystem Impacts on Health

  2024cites this paper
• 2024 Guidelines of the Taiwan Society of Cardiology on the Primary Prevention of Atherosclerotic Cardiovascular Disease --- Part I.

  2024cites this paper
• Sex inequalities in cardiovascular risk prediction

  2024cites this paper
• Mediterranean Diet Adherence and Risk of All-Cause Mortality in Women

  2024cites this paper
• Moderate Associations Between the Use of Levonorgestrel-releasing Intrauterine Device and Metabolomics Profile

  2024cites this paper
• N-Glycosylation Profiles of Immunoglobulin G and Future Cardiovascular Events

  2024cites this paper
• New Advances in Metabolic Syndrome, from Prevention to Treatment: The Role of Diet and Food

  2023cites this paper
• Towards clinical application of GlycA and GlycB for early detection of inflammation associated with (pre)diabetes and cardiovascular disease: recent evidence and updates

  2023cites this paper
• The Mediterranean Diet, Cardiometabolic Biomarkers, and Risk of All-Cause Mortality: A 25-Year Follow-Up Study of the Women’s Health Study

  2023cites this paper
• Serum metabolomics improve risk stratification for incident heart failure

  2023cites this paper
• Combined Association of Novel and Traditional Inflammatory Biomarkers With Carotid Artery Plaque: GlycA Versus C-Reactive Protein (ELSA-Brasil).

  2023cites this paper
• Plasma metabolomics and network pharmacology identified glutamate, glutamine, and arginine as biomarkers of depression under Shuganjieyu capsule treatment.

  2023cites this paper
• Prediagnostic Glycoprotein Acetyl Levels and Incident and Recurrent Flare Risk Accounting for Serum Urate Levels: A Population‐Based, Prospective Study and Mendelian Randomization Analysis

  2023cites this paper
• Improving cardiovascular risk prediction beyond pooled cohort equations: a prospective cohort of 304,356 participants

  2023cites this paper
• Glycoprotein Acetyls: A Novel Inflammatory Biomarker of Early Cardiovascular Risk in the Young

  2022cites this paper
• GlycA, a Biomarker of Low-Grade Inflammation, Is Increased in Male Night Shift Workers

  2022cites this paper
• APOE Genotypes Modulate Inflammation Independently of Their Effect on Lipid Metabolism

  2022cites this paper
• Metabolomic markers of glucose regulation after a lifestyle intervention in prediabetes

  2022cites this paper
• Constructing an atlas of associations between polygenic scores from across the human phenome and circulating metabolic biomarkers

  2022cites this paper
• Immunoglobulin G N-Glycosylation Signatures in Incident Type 2 Diabetes and Cardiovascular Disease

  2022cites this paper
• GlycA, hsCRP differentially associated with MI, ischemic stroke: In the Dallas Heart Study and Multi-Ethnic Study of Atherosclerosis

  2022cites this paper
• Measurement of Serum N-Glycans in the Assessment of Early Vascular Aging (Arterial Stiffness) in Adults With Type 1 Diabetes.

  2022cites this paper
• Association of immunoglobulin G N-glycosylation with carotid atherosclerotic plaque phenotypes and actual clinical cardiovascular events: a study protocol for a longitudinal prospective cohort study

  2022cites this paper
• Metabolomics profile of 5649 users and non-users of hormonal intrauterine devices in Finland.

  2022cites this paper
• Systemic cytokines and GlycA discriminate disease status and predict corticosteroid response in HTLV-1-associated neuroinflammation

  2022cites this paper
• Decreasing severity of obesity from early to late adolescence and young adulthood associates with longitudinal metabolomic changes implicated in lower cardiometabolic disease risk

  2022cites this paper
• Glycosylation and Cardiovascular Diseases.

  2021cites this paper
• Association Between GlycA and Cognitive Function: Cross-Sectional Results From the ELSA-Brasil Study.

  2021cites this paper
• Association of Lipid, Inflammatory, and Metabolic Biomarkers With Age at Onset for Incident Coronary Heart Disease in Women.

  2021cites this paper
• Increased apolipoprotein-B:A1 ratio predicts cardiometabolic risk in patients with juvenile onset SLE

  2021cites this paper
• Investigation of circulating metabolites associated with breast cancer risk by untargeted metabolomics: a case–control study nested within the French E3N cohort

  2021cites this paper
• The First Metabolome Analysis in Children with Epilepsy and ALG13-CDG Resulting from c.320A>G Variant

  2021cites this paper
• Quantification of glycoproteins by nuclear magnetic resonance associated with preclinical carotid atherosclerosis in patients with type 1 diabetes.

  2021cites this paper
• Identification of Metabolic Phenotypes in Young Adults with Obesity by 1H NMR Metabolomics of Blood Serum

  2021cites this paper
• Metabolomics and metabolites in ischemic stroke

  2021cites this paper
• The use of blood biomarkers in precision medicine for the primary prevention of atherosclerotic cardiovascular disease: a review

  2021cites this paper
• Metabolomic connections between schizophrenia, antipsychotic drugs and metabolic syndrome: A variety of players.

  2021cites this paper
• Association between sepsis survivorship and long-term cardiovascular outcomes in adults: a systematic review and meta-analysis

  2021cites this paper
• Association between serum α1-antitrypsin levels and all-cause mortality in the general population: the Nagahama study

  2021cites this paper
• Metabolomic changes in animal models of depression: a systematic analysis

  2021cites this paper
• An atlas of associations between polygenic risk scores from across the human phenome and circulating metabolic biomarkers

  2021cites this paper
• An Overview of Glycosylation and its Impact on Cardiovascular Health and Disease

  2021cites this paper
• Lipoprotein particle alterations due to androgen therapy in individuals with dyskeratosis congenita

  2021cites this paper
• Biomarkers

  2021cites this paper
• Human Serum/Plasma Glycoprotein Analysis by 1H-NMR, an Emerging Method of Inflammatory Assessment

  2020cites this paper
• Novel plasma biomarkers improve discrimination of metabolic health independent of weight

  2020cites this paper
• Association of circulating metabolites in plasma or serum and risk of stroke: Meta-analysis from seven prospective cohorts.

  2020cites this paper
• The metabolic fingerprint of COVID-19 severity

  2020cites this paper
• Circulating branched-chain amino acids and long-term risk of obesity-related cancers in women

  2020cites this paper
• Elevated glycoprotein acetyl levels in adolescence and early adulthood predict adverse cardiometabolic profiles and risk of metabolic syndrome in up to 10 year follow-up

  2020cites this paper
• Sensor of molecular imbalance in metabolic disorder: Determination of molecular behavior wired in disease utilizing metabolomics

  2020cites this paper
• A cross-omics integrative study of metabolic signatures of chronic obstructive pulmonary disease

  2020cites this paper
• A comprehensive metabolic profiling of the metabolically healthy obesity phenotype

  2020cites this paper
• Serum GlycA Level Is Elevated in Active Systemic Lupus Erythematosus and Correlates to Disease Activity and Lupus Nephritis Severity

  2020cites this paper
• Detection of Early Disease Risk Factors Associated with Metabolic Syndrome: A New Era with the NMR Metabolomics Assessment

  2020influential citation
• Inflammation mediates the relationship between obesity and retinal vascular calibre in 11-12 year-olds children and mid-life adults

  2020cites this paper
• Targeting cardiovascular inflammation: next steps in clinical translation.

  2020cites this paper
• Higher plasma GlycA, a novel pro-inflammatory glycoprotein biomarker, is associated with reduced life expectancy: The PREVEND study.

  2019cites this paper
• Associations of Aerobic Fitness and Maximal Muscular Strength With Metabolites in Young Men

  2019cites this paper
• OP0148 METABOLOMICS IN JUVENILE-ONSET SLE: IDENTIFYING NEW BIOMARKERS TO PREDICT CARDIOVASCULAR RISK

  2019cites this paper
• PCSK9 inhibition and inflammation: A narrative review.

  2019cites this paper
• GlycA, a composite low‐grade inflammatory marker, predicts mortality: prime time for utilization?

  2019cites this paper
• Impact of different hypercaloric diets on obesity features in rats: a metagenomics and metabolomics integrative approach.

  2019cites this paper
• GlycA, a novel pro‐inflammatory glycoprotein biomarker is associated with mortality: results from the PREVEND study and meta‐analysis

  2019cites this paper
• Relationship between gut microbiota and circulating metabolites in population-based cohorts

  2019cites this paper
• Sex and puberty-related differences in metabolomic profiles associated with adiposity measures in youth with obesity

  2019cites this paper
• The role of inflammation in the association between overall and visceral adiposity and subclinical atherosclerosis.

  2019cites this paper
• The novel inflammatory marker GlycA and the prevalence and progression of valvular and thoracic aortic calcification: The Multi-Ethnic Study of Atherosclerosis.

  2019cites this paper
• The effect of apolipoprotein E polymorphism on serum metabolome – a population-based 10-year follow-up study

  2019cites this paper
• Composite acute phase glycoproteins with coronary artery calcification depends on metabolic syndrome presence - The Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).

  2019cites this paper
• Markers of Atherosclerosis: Part 1 - Serological Markers.

  2019cites this paper
• Markers of Atherosclerosis: Part 2 - Genetic and Imaging Markers.

  2019cites this paper
• Serum GlycA level is a candidate biomarker for disease activity in systemic lupus erythematosus and for proliferative status of lupus nephritis, independent of renal function impairment

  2018cites this paper
• Circulating Branched-Chain Amino Acids and Incident Cardiovascular Disease in a Prospective Cohort of US Women

  2018cites this paper
• Markers of Inflammation and Incident Breast Cancer Risk in the Women’s Health Study

  2018cites this paper
• GlycA, a novel inflammatory marker, is associated with subclinical coronary disease

  2018cites this paper
• GlycA and hsCRP are independent and additive predictors of future cardiovascular events among patients undergoing angiography: The intermountain heart collaborative study

  2018cites this paper
• Relations of GlycA and lipoprotein particle subspecies with cardiovascular events and mortality: A post hoc analysis of the AIM-HIGH trial.

  2018cites this paper
• Characterization of 1H NMR Plasma Glycoproteins as a New Strategy To Identify Inflammatory Patterns in Rheumatoid Arthritis.

  2018cites this paper
• GlycA, a Nuclear Magnetic Resonance Spectroscopy Measure for Protein Glycosylation, is a Viable Biomarker for Disease Activity in IBD

  2018cites this paper
• Effects of regular endurance exercise on GlycA: Combined analysis of 14 exercise interventions.

  2018cites this paper
• Glycomics and Cardiovascular Disease: Advancing Down the Path Towards Precision.

  2018cites this paper
• Chlamydia pneumoniae Hijacks a Host Autoregulatory IL-1β Loop to Drive Foam Cell Formation and Accelerate Atherosclerosis.

  2018cites this paper
• Protein N-Glycosylation in Cardiovascular Diseases and Related Risk Factors

  2018cites this paper
• Associations of ideal cardiovascular health with GlycA, a novel inflammatory marker: The Multi‐Ethnic Study of Atherosclerosis

  2018cites this paper
• Glycosylation Profile of Immunoglobulin G Is Cross-Sectionally Associated With Cardiovascular Disease Risk Score and Subclinical Atherosclerosis in Two Independent Cohorts

  2018cites this paper
• Adiposity and Genetic Factors in Relation to Triglycerides and Triglyceride-Rich Lipoproteins in the Women's Genome Health Study.

  2018cites this paper
• A Novel Protein Glycan-Derived Inflammation Biomarker Independently Predicts Cardiovascular Disease and Modifies the Association of HDL Subclasses with Mortality.

  2017cites this paper
• Metabolic Phenotype of Obesity in a Saudi Population.

  2017cites this paper